GLP-1 Access and Hidradenitis Suppurativa Trials: What's Moving
Dermatology Times pairs two practice-front stories: how patients secure GLP-1 access and how clinicians can route hidradenitis suppurativa patients into clinical trials.
Topic
Drug Access
Topic